Massachusetts Financial Services Co. MA boosted its stake in Relx Plc (NYSE:RELX - Free Report) by 103.7% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 106,220 shares of the technology company's stock after purchasing an additional 54,062 shares during the quarter. Massachusetts Financial Services Co. MA's holdings in Relx were worth $5,355,000 as of its most recent SEC filing.
A number of other large investors have also bought and sold shares of RELX. Golden State Wealth Management LLC grew its holdings in Relx by 100.0% in the first quarter. Golden State Wealth Management LLC now owns 588 shares of the technology company's stock worth $30,000 after purchasing an additional 294 shares during the period. Cornerstone Planning Group LLC lifted its stake in shares of Relx by 325.2% in the first quarter. Cornerstone Planning Group LLC now owns 693 shares of the technology company's stock valued at $37,000 after buying an additional 530 shares in the last quarter. Transce3nd LLC bought a new position in shares of Relx in the fourth quarter valued at $40,000. Brown Brothers Harriman & Co. lifted its stake in shares of Relx by 218.5% in the fourth quarter. Brown Brothers Harriman & Co. now owns 965 shares of the technology company's stock valued at $44,000 after buying an additional 662 shares in the last quarter. Finally, Redwood Investments LLC bought a new position in shares of Relx in the fourth quarter valued at $120,000. 15.02% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
A number of research firms have weighed in on RELX. Morgan Stanley reaffirmed an "overweight" rating on shares of Relx in a research note on Wednesday, April 16th. The Goldman Sachs Group began coverage on shares of Relx in a research note on Wednesday, March 26th. They issued a "buy" rating for the company. Finally, Wall Street Zen cut shares of Relx from a "buy" rating to a "hold" rating in a research report on Saturday, July 12th. One investment analyst has rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company has an average rating of "Buy".
Read Our Latest Stock Analysis on Relx
Relx Stock Performance
Shares of RELX stock opened at $52.90 on Friday. The firm has a market cap of $97.16 billion, a price-to-earnings ratio of 28.44, a P/E/G ratio of 3.45 and a beta of 0.83. The company has a debt-to-equity ratio of 1.46, a quick ratio of 0.47 and a current ratio of 0.52. Relx Plc has a 52 week low of $43.45 and a 52 week high of $56.33. The firm's 50-day simple moving average is $53.65 and its two-hundred day simple moving average is $51.13.
Relx Profile
(
Free Report)
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Relx, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Relx wasn't on the list.
While Relx currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.